Jan 20, 2008
ASCO GI: Antiangiogenic Agent Shows Promise in Advanced Pancreatic Cancer

SAN FRANCISCO, Jan. 20 -- Patients with unresectable pancreatic cancer had prolonged survival when a cationic liposomal formulation of paclitaxel was added to gemcitabine (Gemzar), a multinational study showed.    <READ MORE>

Sept 23, 2008
Drug Makers Warn of Liver and Kidney Risks with EGFR-Inhibitor

ROCKVILLE, Md., Sept. 23 -- The FDA said today that the makers of the cancer drug erlotinib (Tarceva) have reported two deaths -- one from hepatorenal syndrome and one from rapidly progressing liver failure -- among patients taking the agent.    <READ MORE>

Sept 4, 2008
Comprehensive Blueprints Revealed for Lethal Pancreatic, Brain Cancers

The complete genetic blueprint for lethal pancreatic cancer and brain cancer was deciphered by a team at the Johns Hopkins Kimmel Cancer Center.   <READ MORE>

July 21, 2008
Node Evaluation for Pancreatic and Gastric Cancer Differentiates Hospitals   

CHICAGO, July 21 -- Better gastric and pancreatic cancer survival rates at high-quality, high-volume cancer centers may be partly because of improved staging through more extensive searches during surgery for metastatic nodes, researchers found.      <READ MORE>

May 20, 2008
Pancreatic Cancer: Advances in Diagnosis and Treatment
Tuesday, May 20 11:00 a.m. ET,10:00 CT, 8:00 PT

On-Demand Video of Live Coverage at
Digestive Disease Week 2008

Medical News from
DDW: Digestive Disease Week Meeting

Apr 25, 2008
ASA: Laparoscopic Surgery Gets Good Grades for Pancreatectomy   

NEW YORK, April 25 -- For patients with cancer confined to the pancreatic body or tail, laparoscopic left pancreatectomy leads to less morbidity, lower complication rates, and shorter hospitalization, according to data reported here.     <READ MORE>

Apr 17, 2008
AACR: Drug Combo Shows Promise in Advanced Pancreatic Cancer   

SAN DIEGO, April 17 -- More than 70% of patients with pancreatic cancer derived a clinical benefit when treated in a small, phase I trial with the combination of nanoparticle albumin bound paclitaxel (Abraxane) and gemcitabine (Gemzar), investigators reported here.     <READ MORE>

Mar 4, 2008
Gemcitabine Not a Clear Winner for Adjuvant Treatment of Pancreatic Cancer  

BALTIMORE, March 4 -- Gemcitabine (Gemzar) appears to do little to improve survival for pancreatic cancer patients when added to adjuvant fluorouracil-based chemoradiation after surgery, researchers here found.     <READ MORE>

RNA Patterns May Aid Diagnosis of Pancreatic Cancer (May 01, 2007)